Enhanced host immune recognition of mastitis causing escherchia coli in CD-14 transgenic mice

Animal Biotechnology

Volumn 20, Issue 1, 2009, Pages 1-14

  Wall, R ^a,c   Powell, A ^a   Sohn, E ^b   Foster Frey, J ^a   Bannerman, D ^a   Paape, M ^a  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c Bldg 230 ^*  (United States)

Author keywords

CD 14; Mammary gland; Mastitis; Transgenic mice

Indexed keywords

CD-14; INFLAMMATORY RESPONSE; INNATE IMMUNE RESPONSE; LIPOPOLYSACCHARIDES; MAMMARY GLAND; MASTITIS; PRO-INFLAMMATORY CYTOKINES; TRANSGENIC MICE;

BIOLOGICAL MEMBRANES; CELL CULTURE; ESCHERICHIA COLI; MAMMALS; TISSUE;

DISEASES;

CD14 ANTIGEN; DNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; AORTA; ARTICLE; CATTLE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ESCHERICHIA COLI INFECTION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MASTITIS; METABOLISM; MICROBIOLOGY; MILK; MOUSE; TRANSGENIC MOUSE; UDDER;

ANIMALS; ANTIGENS, CD14; AORTA; CATTLE; DNA; ENDOTHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; FEMALE; GENE EXPRESSION REGULATION; MAMMARY GLANDS, ANIMAL; MASTITIS; MICE; MICE, TRANSGENIC; MILK; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MUS MUSCULUS;

EID: 60649097541     PISSN: 10495398     EISSN: 15322378     Source Type: Journal    
DOI: 10.1080/10495390802594206     Document Type: Article

References (24)

1. Schukken YH, van de GD, Grommers FJ, Smit JA, Brand A. Intramammary Infections and risk factors for clinical mastitis in herds with low somatic cell counts in bulk milk. Vet Rec 1989; 125:393-396.
2. Wurfel MM, Hailman E, Wright SD. Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 1995; 181:1743-1754.
3. Lee JW, Paape MJ, Zhao X. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice. Vet Res 2003; 34:307-316.
4. Lee JW, Paape MJ, Elsasser TH, Zhao X. Recombinant soluble CD14 reduces severity of intramammary infection by Escherichia coli. Infect Immun 2003; 71:4034-4039.
5. Lee JW, Paape MJ, Elsasser TH, Zhao X. Elevated milk soluble CD14 in bovine mammary glands challenged with Escherichia coli 530 lipopolysaccharide. J Dairy Sci 2003; 86:2382-2389.
6. Paape M, Mehrzad J, Zhao X, Detilleux J, Burvenich C. Defense of the bovine mammary gland by polymorphonuclear neutrophil leukocytes. J Mammary Gland Biol Neoplasia 2002;7:109-121.
7. Ferrero E, Jiao D, Tsuberi BZ, Tesio L, Rong GW, Haziot A, Goyert SM. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 1993; 90:2380-2384.
8. Tamura Y, Higuchi Y, Kataoka M, Akizuki S, Matsuura K, Yamamoto S. CD14 transgenic mice expressing membrane and soluble forms: comparisons of levels of cytokines and lethalities in response tolipopolysaccharidebetween transgenic and non-transgenic mice. Int Immunol 1999; 11:333-339.
9. Kerr DE, Plaut K, Bramley AJ, Williamson CM, Lax AJ, Moore K, Wells KD, Wall RJ. Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice. Nat Biotechnol 2001; 19:66-70.
10. Wall RJ, Powell A, Paape MJ, Kerr DE, Bannerman DD, Pursel VG, Wells KD, Talbot N, Hawk HW. Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 2005; 23:445-451.
11. Simons JP, McClenaghan M, Clark AJ. Alteration of the quality of milk by expression of sheep beta-lactoglobulin in transgenic mice. Nature 1987; 328:530-532.
12. Simons JP, Wilmut I, Clark AJ, Archibald AL, Bishop JO. Gene transfer into sheep. Bio/Technology 1988; 6:179-183.
13. Wang Y, Zarlenga DS, Paape MJ, Dahl GE. Recombinant bovine Soluble CD14 sensitizes the mammary gland to lipopolysaccharide. Vet Immunol Immunopathol 2002; 86:115-124.
14. Maga EA, Anderson GB, Murray JD. The effect of mammary gland expression of human lysozyme on the properties of milk from transgenic mice. J Dairy Sci 1995; 78:2645-2652.
15. Nemchinov LG, Paape MJ, Sohn EJ, Bannerman DD, Zarlenga DS, Hammond RW. Bovine CD14 receptor produced in plants reduces severity of intramammary bacterial infection. FASEB J 2006; 20:1345-1351.
16. Jara-Almonte M, White JM. Milk production in laboratory mice. J Dairy Sci 1972; 55:1502-1505.
17. Mitra A, Hruska KS, Wellnitz O, Kerr DE, Capuco AV, Wall RJ. Expression of lysostaphin in milk of transgenic mice affects the growth of neonates. Transgenic Res 2003; 12:597-605.
18. Filipp D, izadeh-Khiavi K, Richardson C, Palma A, Paredes N, Takeuchi O, Akira S, Julius M. Soluble CD 14 enriched in colostrum and milk induces B cell growth and differentiation. Proc Natl Acad Sci USA 2001; 98:603-608.
19. Snijders BEP, Damoiseaux JGMC, Penders J, Kummeling T, Stelmaf F, Van Ree R, et al. Cytokines and soluble CD 14 in breast milk in relation with atopic manifestations in mother and infant (KOALA study). Clinical and Experimental Allergy 2001; 36:1609-1615.
20. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14, and STAT3. Breast Cancer Res 2004; 6:R75-R91.
21. Zheng J, Watson AD, Kerr DE. Genome-wide expression analysis of lipopolysaccharideinduced mastitis in a mouse model. Infect Immun 2006; 74:1907-1915.
22. Archibald AL, McClenaghan M, Hornsey V, Simons JP, Clark AJ. High-level expression of biologically active human alpha 1-antitrypsin in the milk of transgenic mice. Proc Natl Acad Sci USA 1990; 87:5178-5182.
23. Yull F, Harold G, Wallace R, Cowper A, Percy J, Cottingham I, Clark AJ. Fixing human factor IX (fIX): Correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice. Proc Natl Acad Sci USA 1995; 92:10899-10903.
24. Burdon T, Wall RJ, Shamay A, Smith GH, Hennighausen L. Over-expression of an endogenous milk protein gene in transgenic mice is associated with impaired mammary alveolar development and a milchlos phenotype. Mech Dev 1991; 36:67-74.